Improved grading scales for oncology drugs causing ocular adverse events | Optometry Times - Clinical News

Published on January 4, 2026
The grading scales were compiled with the goals of achieving conciseness and the ability to provide clear drug-dose-modification recommendations compared with the previous ocular CTCAE scale.
Continue reading on website
Other news

ONL Therapeutics reports positive phase 1b data for xelafaslatide in GA | Optometry Times - Clinical News

January 4, 2026
Xelafaslatide is a small-molecule Fas inhibitor designed to protect key retinal cells, including photoreceptors, from cell death.

Zyloware and Kenmark Name Victoria Hallberg as Senior Vice President of Sales

January 5, 2026
PORT CHESTER, N.Y.—Zyloware and Kenmark Eyewear have announced the appointment of Victoria Hallberg as senior vice president of sales, effective January 2. In this role, she will oversee all independent accounts across both organizations, the announcement stated, marking an important step in strengthening and unifying the sales process across all brands as the company positions itself for future g